StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2014 it was $25.49B, up 24.2% from the year before. The highest annual figure on record is $25.49B in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2014Dec 28, 2014$25.49B+24.2%
FY2013Dec 29, 2013$20.52B+10.2%
FY2012Dec 30, 2012$18.62B+10.0%
FY2011Jan 1, 2012$16.92B-18.0%
FY2010Jan 2, 2011$20.64B+6.6%
FY2009Jan 3, 2010$19.36B–

More Johnson & Johnson figures

See a number that looks wrong?